Andrew Jenkin has been appointed General Manager GSK Consumer Healthcare, ANZ. The appointment comes after GSK and Pfizer closed the transaction to create a new consumer healthcare Joint Venture yesterday.
These press releases are intended for business journalists and analysts/investors
ARNUITY ELLIPTA (fluticasone furoate), once-daily maintenance therapy for asthma reimbursed by the PBS in Australia
Policy debate needed to ensure Australia remains a global leader in public access to life saving vaccines
Australia’s National Immunisation Program (NIP) is one of the world’s best, achieving some of the highest vaccination rates in the world and supporting community protection against a wide range of vaccine preventable diseases. However, Australia’s timely access to life saving vaccines is under increasing challenge, as the system that assesses which vaccines are included on the NIP falls behind other countries on some issues and may not always match with how the community values prevention.
We are one of the world’s largest science-led pharmaceutical and healthcare companies. Each year we research, manufacture and sell innovative medicines, vaccines and healthcare products for millions of people across the world, helping them to do more, feel better and live longer.